Chlamydia is an infection that causes active inflammation in the genito-urinary organs. Various drugs of different groups are prescribed to treat this disease. The course of treatment of chlamydia is assigned individually to each patient by the individual characteristics of his organism.
With an active inflammatory process, a whole complex of medicines is required for a full course of treatment for chlamydia. The drugs used in the treatment regimens are selected by the physician taking into account the individual characteristics of the patient’s body, the clinical symptoms of the disease, the severity of the inflammatory process and the results of all the tests-immunograms, liver tests, general blood analysis, urine cultures, PCR, ELISA.
To date, the standards of treatment do not imply the appointment of immunostimulants or immunomodulators in the treatment of even complicated chlamydia. Preparations of these groups, except serious cytotoxic drugs that have strict indications and are prescribed only after carrying out the immunogram, should not be used as preparations with unproven effects. Bonuses more often explain shamanism of a large number of urologists, venereologists or gynecologists in this area from pharmaceutical representatives or an attempt to lengthen and increase the cost of treatment for patients of paid clinics and medical centers.
The list of drugs for the treatment of chlamydia must necessarily include a course of immunomodulators. Recent studies show that the use of immunomodulating agents in the treatment of chlamydia and other sexually transmitted diseases speeds up recovery and helps reduce the risk of complications and the transition of the infection to a chronic form.